MedPath

Fluid Volume-hypotension Association in Cesarean Under Neuraxial Anesthesia

Not Applicable
Completed
Conditions
Cesarean Section
Interventions
Drug: Ringer's Lactate
Drug: Six percent hydroxyethyl starch
Registration Number
NCT01013090
Lead Sponsor
Nanjing Medical University
Brief Summary

Hypotension resulted from neuraxial block is a common problem, of which is a special issue in patients undergoing Cesarean section. A large number of studies and clinical guidelines suggest that fluid loading, pre- or co-anesthesia, is a promising manner in preventing hypotension. However, it is still a controversy because the fact of a relatively increased blood volume in parturients. In addition, although it is effective of fluid management, it's precise relationship between fluid (crystalloid or colloid) volume and the proportion of hypotension in Cesarean patients under neuraxial anesthesia is still unknown. The investigators designed this trial to clarify the accurate relationship between fluid volume in an escalated manner and the occurrence of hypotension analyzed with a non-linear regression, and wanted to present the 50% effective volume (EV50) of fluid including crystalloid and colloid in preventing hypotension in patients undergoing Cesarean section.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1000
Inclusion Criteria
  • 21-40 yr
  • First time of delivery
  • ASA status I-II
  • No premature
  • No genetic and infectious diseases
  • Chinese
Exclusion Criteria
  • < 21 yr
  • > 40 yr
  • Subjects with cardiac and pulmonary disorders
  • Dislocation of placenta
  • Pregnant hypertension
  • Allergy to local anesthetics
  • Unwilling to cooperation
  • Need intraoperative administration of vascular active agents
  • With significant delivery side effects
  • With contradictions of neuraxial anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CSEA crystalloidRinger's LactateCrystalloid (Ringer's Lactate) is given pre-, co- and post-CSEA anesthesia in patients undergoing Cesarean section
Spinal crystalloidRinger's LactateCrystalloid (Ringer's Lactate) is given pre-, co- and post-spinal anesthesia in patients undergoing Cesarean section
Epidural colloidSix percent hydroxyethyl starchColloid (6% hydroxyethyl starch) is given pre-, co- and post-epidural anesthesia in patients undergoing Cesarean section
Epidural crystalloidRinger's LactateCrystalloid (Ringer's Lactate) is given pre-, co- and post-epidural anesthesia in patients undergoing Cesarean section
CSEA colloidSix percent hydroxyethyl starchColloid (6% hydroxyethyl starch) is given pre-, co- and post-CSEA anesthesia in patients undergoing Cesarean section
Spinal colloidSix percent hydroxyethyl starchColloid (6% hydroxyethyl starch) is given pre-, co- and post-spinal anesthesia in patients undergoing Cesarean section
Primary Outcome Measures
NameTimeMethod
Rate of hypotensionAnesthesia begin (0 min) to 120 min after anesthesia
Secondary Outcome Measures
NameTimeMethod
Consumption of ephedrine and phenylephrineAnesthesia begin (0 min) to 120 min after anesthesia
Duration of hypotensionAnesthesia begin (0 min) to 120 min after anesthesia
Oxygen saturation during hypotensionAnesthesia begin (0 min) to 120 min after anesthesia
Recurrence of hypotension after ephedrine or phenylephrineAnesthesia begin (0 min) to 120 min after anesthesia
One-min and 5-min Apgar scoresThe first and fifth minute after cesarean successful delivery
Low umbilical cord pH (artery < 7.20)At the time of successful delivery (0 min)

Trial Locations

Locations (1)

Nanjing Maternity and Child Health Care Hospital

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath